Skip to main content

Table 6 Characteristics of patients who developed AKI during follow-up (n = 4944)

From: Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study

  Metformin exposed AKI event AKI event without concurrent metformin exposure
(n = 1972) (n = 2972)
Age (Years) a 73.6 (65.7 – 79.4) 77.6 (70.4-83.7)
Male Sex (%) 1161 (58.9) 1533 (51.6)
HbA1c % 7.2 (6.5- 8.3) 6.8 (6.2- 7.9)
(mmol/mol) a 55 (48- 67) 51 (44- 63)
Diabetes Duration (years) a 9.15 (5.11- 13.85) 7.50 (3.30-13.76)
Number of diabetes drug classes (%)
0 13 (0.7) 1745 (58.7)
1 830 (42.1) 1049 (35.3)
2 897 (45.5) 162 (5.5)
3 212 (10.8) 16 (0.5)
4 19 (1.0) 0 (0.0)
5 1 (0.1) 0 (0.0)
CKD category (%)
>60 941 (47.7) 986 (33.2)
30-59 896 (45.4) 1476 (49.37)
<29 ml/min/1.732 130 (6.6) 492 (16.6)
  1. aMedian & IQR